ED
Program

Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Global Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaSouth KoreaSwitzerlandTunisiaTürkiyeUkraineUnited KingdomEgyptMoroccoBJBFBICMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZWGrant
About

Four grants of EUR 8,475,000 each are funded from this topic's EUR 33,900,000 budget through a two-stage call, with the first stage open to all applicants and a second, invited-only stage. Proposals evaluating monoclonal antibodies should specifically aim to lower production costs to improve accessibility, and consortia must include at least three independent legal entities from different eligible…

Industries covered
BiotechMedtech
Grants under Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa
Closed

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

€33.9M pool